Literature DB >> 956095

Effect of adrenergic agents and their mode of action on mucociliary clearance in man.

W M Foster, E H Bergofsky, D E Bohning, M Lippmann, R E Albert.   

Abstract

The aerosolized adrenergic (ADR) agent, isoproterenol (ISO), was found markedly to accelerate mucus clearance within the human tracheobronchial tree. Mucus transport was measured by external gamma counting of aerosolized Fe2O3 particles deposited on the mucous membrane during inhalation. Aerosolized epinephrine (EPI), despite its alpha-ADR bronchial vasoconstrictor activity, increased mucus clearance to the same degree as did aerosolized ISO, with its beta-ADR bronchial vasodilator activity. The vehicle used for delivery of the ADR agents, i.e., a H2O aerosol by intermittent positive-pressure breathing (IPPB), itself increased mucus clearance slightly, but did not elicit the enormous increases produced by the ADR agents. Parenteral ISO caused increases in clearances similar to aerosolized ISO and EPI (consistent with different tissue drug levels achieved). Oral atropine delayed clearance, but atropine prior to an ADR aerosol did not alter the mucus transport effect of the ADR agent. ISO and atropine, despite opposite effects on mucus clearance, caused equal bronchodilation. Thus, increased clearance following aerosolized ISO was not dependent on bronchial vasodilation, aqueous aerosol droplets, reflex parasympathetic activation, or bronchodilation, and seems best attributable to increased ciliary beat rate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956095     DOI: 10.1152/jappl.1976.41.2.146

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  20 in total

Review 1.  The influence of drugs on nasal ciliary movement.

Authors:  W A Hermens; F W Merkus
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

2.  Effect of selective and non-selective beta blockade on pulmonary function and tracheobronchial mucociliary clearance in healthy subjects.

Authors:  D Pavia; J R Bateman; A M Lennard-Jones; J E Agnew; S W Clarke
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

Review 3.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 4.  Particle deposition and clearance in the bronchial tree.

Authors:  D B Yeates; T R Gerrity; C S Garrard
Journal:  Ann Biomed Eng       Date:  1981       Impact factor: 3.934

5.  Imaging of the airways by bronchoscintigraphy for the study of mucociliary clearance.

Authors:  S Groth; J Mortensen; P Lange; E P Munch; P G Sørensen; N Rossing
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 6.  Deposition, retention, and clearance of inhaled particles.

Authors:  M Lippmann; D B Yeates; R E Albert
Journal:  Br J Ind Med       Date:  1980-11

Review 7.  Lung mucus production and mucociliary clearance: methods of assessment.

Authors:  S W Clarke; D Pavia
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

8.  Desensitization of PKA-stimulated ciliary beat frequency in an ethanol-fed rat model of cigarette smoke exposure.

Authors:  Todd A Wyatt; Martha J Gentry-Nielsen; Jacqueline A Pavlik; Joseph H Sisson
Journal:  Alcohol Clin Exp Res       Date:  2004-07       Impact factor: 3.455

9.  Mucociliary clearance in patients with chronic autonomic failure.

Authors:  P Jenkins; D Pavia; J R Bateman; S W Clarke; K M Citron; R Bannister
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

10.  Effects of terbutaline sulphate aerosol on bronchodilator response and lung mucociliary clearance in patients with mild stable asthma.

Authors:  J R Bateman; D Pavia; N F Sheahan; S P Newman; S W Clarke
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.